NCT00204243View on ClinicalTrials.gov

Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

December 31, 2008

Conditions
Opiate Addiction
Interventions
DRUG

Naltrexone

surgically implanted naltrexone releasing during 5 to 6 months

DRUG

Methadone

Methadone maintenance treatment, flexible high dose (80 to 120 mg / Day)

Trial Locations (1)

0407

Unit for Addiction Medicine, Oslo

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

lead

University of Oslo

OTHER

NCT00204243 - Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services | Biotech Hunter | Biotech Hunter